Erectile dysfunction, or impotence, is seen in approxi mately 50% of the male diabetic population in the United States. Erectile dysfunction is dependent upon an intricate interaction of psychologic, vascular, hormonal, and neurologic factors. This paper reviews the evaluation of organic impotence in the male diabetic patient and describes several treatments including pharmacologic modalities and surgical procedures.
Get full access to this article
View all access options for this article.
References
1.
Waxman SGPathophysiology of nerve conduction: Relation to diabetic neuropathy. Ann Intern Med1980;92:297-301.
2.
Whitehead ED , Kyle BJ, et al. Male sexual dysfunction and diabetes mellitus, multi-disciplinary approach to diagnosis and management. NY State J Med1983;83:1174-79.
3.
Fairburn CG,McCulloch DK, Wu FCThe effects of diabetes on male sexual function. Clin Endocrinol Metab1982;2:749-67.
4.
Ellenberg M.Impotence in diabetes: the neurologic factor . Ann Intern Med1971;75:213-19.
5.
Montenero P. , Donatone E.Diabete et activitè sexuelle chez l'homme . Diabete1962;10:327-35.
6.
Renshaw DCSexual problems in old age, illness and disability. Psychosomatics1981;22:975-85.
7.
Green R., Wagner G.Impotence: physiological, psychological, surgical diagnosis and treatment . New York: Plenum Press, 1981.
Buck AC, Reed PI, Siddiq YK, et al. Bladder dysfunction and neuropathy in diabetes. Diabetologia1976; 12:251-58.
10.
Faerman I., Glover L., Fox D., Jadzinskly M., Rapaport M.Impotence and diabetes: histological studies of the autonomic nervous fibers of the corpora cavernosa in impotent diabetic males. Diabetes1974;23:971-76.
11.
Gaskell P.The importance of penile blood pressure in cases of impotence. J Can Med Assoc1971;105:1047-51.
12.
Goldstein I. , Siroky MB, Nath RL, et al. Vasculogenic impotence: role of the pelvic steal test. J Urol1982;128:300-306.
13.
Abber JC, Lue TF, Orvis BR, McClure RD, Williams RDDiagnostic tests for impotence: a comparison of papaverine injection with the penile-brachial index and nocturnal penile tumescence monitoring. J Urol1986;135:923-25.
14.
Bradley WE, Timm GW, Gallagher JM, et al. New method for continuous measurement of nocturnal penile tumescence and rigidity. Urology1985;26:64-68.
15.
Ek A., Bradley WE, Krane RJNocturnal rigidity measured by the snap-gauge band. J Urol1983;129:964-66.
Krane RS, Siroky MBStudies on sacral-evoked potential. J Urol1980; 124:872-76.
18.
Comfort A, ed. Joy of sex. New York: Crown Publisher, 1972.
19.
Zorgniotti AW, LaFleur RSAuto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence. J Urol1985;133:39-41.
20.
Padma-Nathan H., Goldstein I., Krane RJTreatment of prolonged or priapistic erections following intracavernosal papaverine therapy. SeminUrol1986;4:236-38.
21.
Morales A., Surridge DH, Marshall PG, Fenemore J.Non-hormonal pharmacological treatment of organic impotence. J Urol1982; 128:45-47.
22.
Michal V., Kramar R., Hejhal L.Revascularization procedure of the cavernous bodies. In: Zorgniotti AW, Rossi G, eds. Vasculogenic impotence, proceedings of the first international conference on corpus cavernosum revascularization. Springfield, Illinois: Charles C Thomas, 1980 :239-55.
23.
Merrill D.Clinical experience with Mentor inflatable penile prosthesis in 206 patients . Urology1986;28:185-89.
24.
Fishman I.Experience with the Hydroflex penile prosthesis. SeminUrol1986;4:239-43.
25.
Kaufman JJ, Boxer RJ, Boxer B., Quinn MDPhysical and psychological results of penile prostheses: statistical survey . J Urol1981;126:173-75.
26.
Beutler L., Scott FB, Karacan I., et al. Women's satisfaction with partners' penile implant. Urology1984;24:552-58.
